Sched.com Conference Mobile Apps
FierceBiotech 2nd Drug Development Forum
has ended
Create Your Own Event
FierceBiotech 2nd Drug Development Forum
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
Clinical Research Outsourcing and Technology
Digital Technology and Real-World Evidence
Improving R&D Outcomes
Networking
Plenary Sessions Day 1
Registration
Strategic Deal Making
Workshop Day
Popular
menu
Menu
Schedule
Speakers
Search
tune
Filter sessions
Simple
Expanded
Grid
By Venue
Monday
, September 25
Renaissance Boston Waterfront
8:00am •
Registration and Continental Breakfast
9:00am •
Workshop A: Accelerate Design of Adaptive Clinical Trials for Different Patient Populations
9:00am •
Workshop B: Encourage Growth of Partnerships Between Biotech and Academia
1:00pm •
Workshop C: Make Meaningful Advances in a Hyper-Competitive Immuno-Oncology Market
1:00pm •
Workshop D: Reduce the Failure Rate in CNS Trials by Managing Placebo Response
4:00pm •
Welcome Reception
Tuesday
, September 26
Renaissance Boston Waterfront
8:00am •
Registration and Continental Breakfast
8:45am •
Opening Remarks
9:00am •
Chart the Clearest Path to Drug Approval
9:50am •
Networking Break
10:00am •
Industry Strategy on Drug Pricing: Making a Better Second Impression
10:50am •
Networking Break
11:00am •
Cultivate Diversity in the Biotech Sector
11:50am •
Networking Break
12:00pm •
Fierce15 Veterans Panel: Lessons Learned on the Journey
12:30pm •
Luncheon
1:45pm •
Let’s Make a Deal: Analyze the Success of Inorganic Growth Strategies in Biopharma R&D
1:45pm •
Define and Implement Optimized Sourcing Strategy and Oversight Approach
1:45pm •
Ensure That Innovative R&D Companies Are Rewarded for Taking Risks
2:30pm •
Improve Clinical Oversight through Enhanced Visibility Tools
2:30pm •
Anticipate the Responses and Judgments of Venture Capitalists to a Crowded Market
2:30pm •
Model-Aided Drug Invention (MADI) Case Studies: Quantitative Modeling and Simulation Approaches Driving Critical Decisions from Research through Clinical Trials
2:30pm •
Transition to a More Personalized Approach to Working with Patients in Specialty Markets
3:15pm •
Enable Flexibility, Creativity and Independence in Partnerships Between Large and Small Biotech Companies
3:15pm •
Ensure Success in a Highly Partnered Business Model
3:15pm •
Accelerate Product Concept to Clinical Testing by Going Well Beyond the Virtual Company Model
3:15pm •
Compare Trends, Challenges and Development Paths for Repositioning Drugs
4:00pm •
Networking Break
4:30pm •
Avoid Desperation by Precision Expectations with Venture Capitalists
4:30pm •
Focus on Sponsor Accountability for CRO Oversight
4:30pm •
Prioritize Cost-Effectiveness for New Therapeutics
4:30pm •
Digital Technology and Real-World Evidence
5:15pm •
Evaluate the Risks and Benefits of Deal Complexity: What Really Generates Value?
5:15pm •
Evaluate the Prospective Match Between CROs and Sponsors
5:15pm •
Revolutionize Clinical Insight Through Proper Real-World Data Instrument Collection Design
5:15pm •
Unlock the Value of Indications That Are of Incubatory Interest to Larger Pharma
6:00pm •
Cocktail Reception & Fierce15 Awards
TBA
1:45pm •
Harness the Value of Real-World Evidence Across the Product Lifecycle
Wednesday
, September 27
Renaissance Boston Waterfront
8:00am •
Registration and Continental Breakfast
9:15am •
Bring Novel Medical Devices and Wearables to Bear on Clinical Trials
9:15am •
Secure Funding for Preclinical Companies
9:15am •
Shorten the Path from Preclinical to Clinical Phases
9:15am •
Prioritize and Evaluate Phase 4 Studies
10:00am •
Capitalize on Upcoming FDA Initiatives to Tap New Sources of Trial Data
10:00am •
How to Succeed in Novel Deal Structures (Even If They’re Trying)
10:00am •
Bridge the Cultural Divide Between Small Biotechs and Large CROs
10:00am •
Grasp Combination and Patient Engagement Approaches in Immuno-Oncology
10:45am •
Networking Break
11:15am •
Bring Biomarkers, Patient Empowerment and Trial Design Together to Improve Drug Development Efficiency
11:15am •
Highlight the Warning Signs of Failure in Strategic Partnerships
11:15am •
Conduct Research in an Externalized Environment
11:15am •
New Company Formation: Evolving Business Strategies & Financing Models
12:00pm •
Strategize First-In-Human CAR-T and TCR-T Study Designs
12:00pm •
Utilize Real-World Evidence to Bring Forward New Indications
12:00pm •
Build the Deal – Don’t Buy It
12:00pm •
Lower Clinical Development Time and Costs when Working in China
12:45pm •
Luncheon
1:45pm •
Build Internal Multi-Division Teams for Successful Product Advancement
1:45pm •
Pioneer Novel Deal Structures in a Changing Marketplace
1:45pm •
Accelerate Drug Development Through Improved Patient Engagement and Social Media Management
1:45pm •
Select and Strategize with CROs for Preclinical Research
2:30pm •
Add Orphan Indications to Accelerate Development
2:30pm •
Fine-Tune Partnerships for Rare Disease Clinical Trials
2:30pm •
Attract Informatics Talent and Resources Necessary for Patient Centricity and Personalized Medicine
2:30pm •
Achieve Commercial Success with Peptide Therapeutics for Chronic Diseases Through Target Selection and Product Planning
Timezone
FierceBiotech 2nd Drug Development Forum
America/New York
Filter By Date
FierceBiotech 2nd Drug Development Forum
Sep 25
-
27, 2017
Monday
, September 25
Tuesday
, September 26
Wednesday
, September 27
Filter By Venue
Boston, MA, United States
Sort schedule by Venue
Renaissance Boston Waterfront
TBA
Filter By Type
Clinical Research Outsourcing and Technology
Digital Technology and Real-World Evidence
Improving R&D Outcomes
Networking
Plenary Sessions Day 1
Registration
Strategic Deal Making
Workshop Day
Filter sessions
Apply filters to sessions.
close
Dates
Monday
, September 25
Tuesday
, September 26
Wednesday
, September 27
Venue
Renaissance Boston Waterfront
TBA
Session Type
Clinical Research Outsourcing and Technology
Digital Technology and Real-World Evidence
Improving R&D Outcomes
Networking
Plenary Sessions Day 1
Registration
Strategic Deal Making
Workshop Day
Other Filters
